KINETICS OF CD11B EXPRESSION ON NEUTROPHILS ISOLATED FROM SUBJECTS WITH HEALTHY GINGIVAE AND PATIENTS WITH ADVANCED PERIODONTITIS

被引:9
作者
WATANABE, K
HAGEN, KL
RAMAKRISHNAN, V
ANDERSEN, BR
机构
[1] UNIV ILLINOIS, CTR RES RESOURCE, CHICAGO, IL 60680 USA
[2] UNIV ILLINOIS, SCH PUBL HLTH, DEPT BIOSTAT, CHICAGO, IL 60680 USA
[3] UNIV ILLINOIS, SCH MED, DEPT MED, INFECT DIS SECT, CHICAGO, IL 60680 USA
[4] W SIDE VET ADM MED CTR, CHICAGO, IL USA
关键词
CD11B CD18; NEUTROPHILS; FLOW CYTOMETRY; PERIODONTITIS;
D O I
10.1111/j.1600-0765.1993.tb01061.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The adhesion molecule, CD11b/CD18, plays a role in host defense against bacterial infections owing to its involvement in cell migration and phagocytosis. We examined the kinetics of CD11b expression on neutrophils isolated from peripheral blood (PB-PMNs) and gingival crevicular fluid (CF-PMNs) in subjects with healthy gingivae and in patients with advanced periodontitis in order to assess if CF-PMNs respond differently in regard to CD11b expression from PB-PMNs isolated from healthy or periodontitis subjects. CF-PMNs or formylmethionylleucylphenylalanine (fMLP)-stimulated PB-PMNs were incubated in buffer with or without divalent cations for 60, 90, or 110 minutes. Plasma membrane (surface) CD11b as measured by flow cytometry was found to be reduced with time when cells (PB-PMNs or CF-PMNs) from either controls or patients were treated with calcium- and magnesium-free buffer. However, when CF-PMNs were treated with buffer containing Ca++/Mg++, surface CD11b expression increased on cells from both controls and patients. The reduction in CD11b expression on PB-PMNs is significantly greater than that measured on CF-PMNs over time. Therefore, CF-PMNs respond differently from PB-PMNs which have been artifically stimulated with fMLP in regard to kinetics of CD11b expression on the plasma membrane.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 22 条
[1]  
ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175
[2]   AMINO-ACID SEQUENCE OF THE ALPHA-SUBUNIT OF HUMAN-LEUKOCYTE ADHESION RECEPTOR MO1 (COMPLEMENT RECEPTOR TYPE-3) [J].
ARNAOUT, MA ;
GUPTA, SK ;
PIERCE, MW ;
TENEN, DG .
JOURNAL OF CELL BIOLOGY, 1988, 106 (06) :2153-2158
[3]  
BERGER M, 1985, J IMMUNOL, V135, P1342
[4]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[5]   SURFACE EXPRESSION OF GP165/95, THE COMPLEMENT RECEPTOR CR3, AS A MARKER OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BUYON, JP ;
SHADICK, N ;
BERKMAN, R ;
HOPKINS, P ;
DALTON, J ;
WEISSMANN, G ;
WINCHESTER, R ;
ABRAMSON, SB .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (01) :141-149
[6]   INTERNALIZATION PATHWAY OF C3B RECEPTORS IN HUMAN NEUTROPHILS AND ITS TRANSMODULATION BY CHEMOATTRACTANT RECEPTORS STIMULATION [J].
CARPENTIER, JL ;
LEW, DP ;
PACCAUD, JP ;
GIL, R ;
IACOPETTA, B ;
KAZATCHKINE, M ;
STENDAHL, O ;
POZZAN, T .
CELL REGULATION, 1991, 2 (01) :41-55
[7]   AGGREGATION OF COMPLEMENT RECEPTORS ON HUMAN-NEUTROPHILS IN THE ABSENCE OF LIGAND [J].
DETMERS, PA ;
WRIGHT, SD ;
OLSEN, E ;
KIMBALL, B ;
COHN, ZA .
JOURNAL OF CELL BIOLOGY, 1987, 105 (03) :1137-1145
[8]  
GRAHAM IL, 1991, J IMMUNOL, V146, P685
[9]  
JACK RM, 1988, J IMMUNOL, V140, P4286
[10]  
LIMB GA, 1988, CLIN EXP IMMUNOL, V71, P362